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Familial biparental hydatidiform mole (FBHM) is the only known pure maternal-effect recessive inherited disorder in humans. Affected
women, although developmentally normal themselves, suffer repeated pregnancy loss because of the development of the conceptus into
a complete hydatidiform mole in which extraembryonic trophoblastic tissue develops but the embryo itself suffers early demise. This
developmental phenotype results from a genome-wide failure to correctly specify or maintain a maternal epigenotype at imprinted
loci. Most cases of FBHM result from mutations of NLRP7, but genetic heterogeneity has been demonstrated. Here, we report biallelic
mutations of C6orf221 in three families with FBHM. The previously described biological properties of their respective gene families
suggest that NLRP7 and C6orf221 may interact as components of an oocyte complex that is directly or indirectly required for determi-
nation of epigenetic status on the oocyte genome.Normal mammalian development requires biparental
genetic contributions because of the phenomenon of
genomic imprinting.1 Although at most genetic loci the
paternal and maternal alleles are functionally equivalent
and biallelically transcribed, a small subset of genes deviate
from this general pattern. At these imprinted loci, different
epigenetic modifications arise on the maternal and
paternal alleles, resulting in differential gene expression
(which may be temporally or spatially restricted2).
Although there is considerable diversity in the genomic
architecture andphysiological functionof imprintedgenes,
some general observations may be made. (1) Many im-
printed genes occur in clusters, which may include pater-
nally, maternally, and biallelically expressed genes but
which may be subject to coordinated control by locus
control elements (imprinting control regions [ICRs]3). (2)
Most imprinted loci depend for correct function on a
primary epigeneticmark established on thematernal allele;
only a small number of paternally-specified primary
imprints have been identified.4 (3) In female mice, nuclear
transplantation experiments have defined unique, locus-
specific temporal windows during which an imprint can
be established on maternal alleles as they pass through
oogenesis.5
A variety of human developmental phenotypes result
from incorrect imprint specification or dosage. In several
cases, the phenotype resulting from a uniparental disomy
(e.g., Prader-Willi syndrome [MIM 176270], maternal
uniparental disomy 15) is closely mimicked by that due
to an ICR mutation (e.g., that results in a genetically1Section of Genetics, Leeds Institute of Molecular Medicine, St. James’s Unive
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function).6 Such defects are cis-acting, the status of other
imprinted chromosomal loci being unaffected.
Complete hydatidiform mole (CHM) represents an
extreme example of a human developmental phenotype
attributable to abnormal imprinting. In most CHM, the
conceptus is wholly androgenetic in origin.7 This results
in proliferation of the extraembryonic trophoblast, while
embryonic development fails. CHM is generally a sporadic
disorder, but a rare familial form of the disorder has been
long recognized, in which affected women suffer recurrent
molar pregnancies. Notably, in this familial form of the
disorder the molar tissues are not androgenetic, but show
a normal pattern of biparental diploid inheritance. This
condition, familial biparental hydatidiform mole (FBHM
[MIM 231090]) displays maternal-effect autosomal reces-
sive inheritance.8
We and others9–13 have previously shown that FBHM is
a consequence of a failure to establish maternal imprints at
multiple genome-wide loci. This multilocus imprinting
failure suggests that the genetic defect must be trans-
acting. The autosomal recessive inheritance of FBHM is
thus consistent with the idea that affected (homozygous
mutant) mothers are deficient in a trans-acting gene
product. This contrasts with the cis-acting effect and auto-
somal dominant inheritance pattern that characterize
locus-specific ICR defects.2
In 2006, Slim and colleagues14 identified recessive
mutations in NLRP7 (MIM 609661) as a cause of FBHM;
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Figure 1. Pedigree of Family L
The proband is designated by the arrow; individuals V:3 and IV:5 are the affected individuals. CHM are displayed as clear diamonds.
Miscarriages are displayed as small triangles.suggested that NLRP7 is mutated in the majority of FBHM
families.11,13,15–17 However, we have previously shown
that the original family (family L11,12) in which the
FBHM imprinting defect was demonstrated is unlinked to
the NLRP7 locus on chromosome 19. This and other
reports of confirmed FBHM cases that do not harbor
NLRP7 mutations support the existence of locus heteroge-
neity.11,15,17 Here, we show that mutations in C6orf221,
a member of a rapidly evolving gene family specific to
eutherian mammals, are a cause of FBHM.
All patient samples were obtained after written informed
consent. Samples from family L, were obtained according
to a protocol approved by the Leeds (East) Research Ethics
Committee (reference 07/H1306/113). Other individuals
analyzed provided samples following protocols approved
by the institutional review board of the CHU Farhat
Hached or by the Riverside Research Ethics Committee
(RREC 2652).
In family L, (Figure 1), a multiply consanguineous family
of Pakistani origin, two related women, individuals V:3
and IV:5, had clinically typical, recurrent CHM, confirmed
in the index case to be biparental.12 We used these two
individuals to perform a homozygosity scan using the Af-
fymetrix Genome-Wide Human SNP Array 6.0. Genotype
data were analyzed using AutoSNPa18 and IBDfinder soft-
ware.19 Six regions of concordant homozygosity larger
than 2 Mbp and encompassing a total genomic interval
of 78 Mbp were shared by both affected women (Table
S1, available online).
To enrich for sequences of interest, we used the Agilent
SureSelect Target Enrichment (Agilent, Santa Clara, CA,
USA) in-solution method to capture RefSeq coding exons
within the target interval identified in for family L. We de-
signed biotinylated oligonucleotide baits by extracting all
coding regions from the UCSC Genome Browser 8 for the
5451 unique RefSeq genes in the two loci. These regions
were uploaded to Agilent’s eArray software for automated452 The American Journal of Human Genetics 89, 451–458, Septemboligonucleotide synthesis (in parallel with regions for
seven other unrelated loci as part of a collaborative exper-
iment). Three micrograms of genomic DNA was sheared
and Illumina paired-end adapters were ligated according
to Agilent’s SureSelect Library Prep protocol version 1.0.1
(October 2009). Samples were size selected (200–300 bp)
on an agarose gel followed by 12 cycles of PCR enrichment
prior to hybridization to the SureSelect reagent for 24 hr at
65C (following protocol version 1.0.1). A posthybridiza-
tion amplification step was performed and samples were
subsequently cleaned up with Ampure SPRI beads (Beck-
man-Coulter, High Wycombe, UK).
We denatured libraries with NaOH and diluted to a final
concentration of 12 pM, 120 ml of which was hybridized
onto a v5 single-read flow cell (Illumina, San Diego, CA,
USA) according to the manufacturer’s cluster station
instructions. Samples were prepared for sequencing accord-
ing to Illumina’s standard amplification, linearization,
blocking, and primer hybridization protocols. The flow
cell was then transferred to the Illumina GAIIx for sequenc-
ing with an adapted single-read protocol for 80 cycles.
Raw data files were processed by the Illumina pipeline
(version 1.3.4) and sequence reads aligned to the human
reference sequence (hg19/GRCh37) with Novoalign short-
read alignment software (Novocraft Technologies, Selangor,
Malaysia). Duplicate reads, resulting from PCR clonality or
optical duplicates, and reads mapping tomultiple locations
were excluded from downstream analysis. Alignment files
were further processed with the SAMtools program20 and
the Genome Analysis Toolkit.21,22 Mean depth of coverage
for targeted regions was 74.81, with 93.7% of target bases
covered by at least five reads of sufficient base quality
for variant calling (phred quality scores R 17). Variants
within the candidate regions were called in the VCF format
using the Unified Genotyper and DINDEL23 functions of
GATK. Variants were filtered using GATK on the basis of
mapping quality, strand bias, and genotype quality.er 9, 2011
Figure 2. Mutations Identified in C6orf221 in Three Cases of FBHM
The following abbreviations are used: WT, wild-type; family L, c.3G>T homozygote; family T, c.322_325delGACT homozygote; family
W, compound heterozygote c.1A>G þ c.322_325delGACT.Six hundred and forty-two variants matching known
SNPs present in dbSNP131 were removed, leaving 15 func-
tional variants (missense, stop loss, nonsense, indels and
splice site) not annotated in dbSNP131. Of the 15 novel
variants, seven were identified in at least one of the other
samples captured and sequenced alongside the FBHM
proband and was therefore likely to represent nonpatho-
genic variation.
The remaining eight variants all resulted in missense
changes in their respective encoded proteins (Table S2).
In order to identify potentially pathogenic variants, we
used SIFT to identify variants likely to affect protein func-
tion.24 Only two variants were predicted to be damaging.
The first of these was a valine to aspartate substitution
(c.632T>A; p.Val211Asp) in TAAR8 (NM_053278.1), which
encodes a trace amine-associated receptor. Members of the
TAAR family are exclusively expressed in the olfactory
epithelium, where they seem to play a chemosensory
role related to the detection of social cues.25 The TAAR
family displays an evolutionary pattern similar to that of
olfactory receptors,26 and the presence of a common
TAAR8 nonsense SNP (rs77605736, c.142G>T; p.Gly48*)
with an allele frequency of 8.3% suggests that this gene
is dispensable in humans. This variant was therefore
considered unlikely to be pathogenic.
The remaining predicted damaging variant alters the
initiation codon of C6orf221 (NM_001017361.2) from
ATG to ATT (c.3G>T) (Figure 2). The next available down-
stream ATG codon lies at residue 14 of the putative
C6orf221 protein (predicted from reference sequence
NM_001017361.2) and is in frame. The c.3G>T mutation
segregated with the disease in family L and was not found
in 328 ethnically matched control chromosomes.
To investigate whether the c.3G>T mutation results
in the use of the downstream ATG at position 14, we
used in vitro gene-transfer analysis. pcDNA3.1myc-HisThe American(Invitrogen, Renfrew, UK) expression constructs for wild-
type and mutant proteins were created; restriction site-
tagged cDNAs were amplified from IMAGE clone
40146866 template DNA, with 20 cycles of PCR with Pfu
polymerase (Stratagene, Stockport, UK) under manufac-
turers’ recommended conditions. The mutant construct
was generated by use of the Quikchange mutagenesis kit
(Stratagene, UK). Primer sequences for generation of the
wild-type and mutant constructs are listed in Table S3.
We cultured HEK293 cells (ECACC, Salisbury, UK) in
MEM, 5% fetal bovine serum, and 2 mM glutamine and
transfected themwith the vectors described above by using
Lipofectamine 2000 (Invitrogen) according to the manu-
facturers’ instructions. Whole-cell protein extracts were
resolved with SDS-PAGE, and immunoblotted. Blots were
probed with a commercial mouse monoclonal Myc anti-
body (Sigma-Aldrich, Irvine, UK) and with a custom-
made rabbit polyclonal antibody raised against a peptide
antigen (MDAPRRFPTLVQLMQC) containing residues
1–15 of human C6orf221. Figure 3 shows that as expected,
a shortened protein is produced consequent upon the
c.3G>T mutation. Also as expected, this mutant protein
is not detected by the N-terminal C6orf221 antibody.
These results are consistent with the initiation of the
mutant protein at position 14.
We next analyzed probands from a further 14 cases of
recurrent hydatidiform mole in which NLRP7 mutations
had not been identified on sequencing. Conventional
Sanger sequencing of C6orf221 was performed using PCR
primers that flanked all coding exons of C6orf221. These
were designed using the ExonPrimer program (Table S4).
Direct sequencing was performed using the dideoxy-
chain-termination method (ABI BigDye 3.0 system) on
an ABI 3730 DNA Sequencer and sequences analyzed
with Chromas v2.0 software. All mutations were verified
bidirectionally.Journal of Human Genetics 89, 451–458, September 9, 2011 453
Figure 3. Effect of c.3G>T Mutation on C6orf221
HEK293 cells (ECACC, Salisbury, UK) were transfected with Myc-
tagged wild-type or c.3G>T C6orf221 containing vectors. Whole-
cell protein extracts were resolved with SDS-PAGE and immuno-
blotted. Blots were probed with a commercial mouse monoclonal
c-Myc antibody (Sigma-Aldrich, Irvine, UK) and with a custom-
made rabbit polyclonal antibody raised against a peptide antigen
(MDAPRRFPTLVQLMQC) containing residues 1–15 of human
C6orf221. The following abbreviations are used: C, negative
control; Wt ,wild-type protein; M1V, site directed mutagenesis
produced a protein with the initiation codon mutation. In lanes
1, 2, and 3, the probe used is the anti-c-Myc antibody. The expected
24 kDa wild-type C6orf221 is detected in lane 2; in lane 4 the
shorter protein is seen consequent upon the c.3G>T mutation.
In lanes 6, 7, and 8, the probe used is the antibody raised against
N-terminal peptide. In lane 7 the expected 24 kDa wild-type
C6orf221 is detected. The peptide antibody fails to detect the
protein produced from the vector containing the c.3G>T muta-
tion run in lane 8. This is consistent with the predicted initiation
at codon 14 as a result of the mutation.In an affected individual of Tunisian origin (indivi-
dual T1), we identified a homozygous 4 bp deletion
(c.322_325delGACT; p.Asp108Ilefs*30) in exon 2 of
C6orf221 (Figure 2C). Details of this case have been re-
ported previously, and the molar tissue has again been
proven to be biparental.27 This mutation was not present
in 208 Tunisian control chromosomes. It results in a frame-
shift at amino acid 108 and premature termination after 29
novel amino acid residues. The truncated protein thus
lacks its normal 110 C-terminal amino acids, including
the entire exon 3-encoded repeat motif (discussed below).
In a further nonconsanguineous FBHM patient of Asian
origin (individual W1, case 20 of Wang et al.17), we found
compound heterozygosity for two mutations, c.1A>G
and the 4 bp c.322_325delGACT mutation in exon 2.
Sequencing of cloned PCR products spanning exons 1
and 2 confirmed that these two mutations were on
opposite alleles (data not shown.) Inspection of data
from the 1000 Genomes Project alignment files showed
that the c.1A>G mutation was absent from all 1127 indi-
viduals for which a genotype could be called, including
734 individuals with genotype phred scale quality scores
of R 30. The exon 2 deletion was similarly not found in
1145 individuals for whom a genotype could be called,454 The American Journal of Human Genetics 89, 451–458, Septembincluding 739 at a minimum genotype phred scale quality
score of 30.
Clinical details of these cases are found in Table S5. They
are typical FBHM, indistinguishable clinically from those
with NLRP7 mutations.
We next investigated the expression of C6orf221
by using RT-PCR on amplified cDNA derived from a
developmental series of staged human ovarian follicles,
oocytes, preimplantation embryos, and human blasto-
cysts. Methods for sample origination, preparation, and
validation have been described.28–30 Briefly, human
ovarian follicles were isolated after enzymatic digestion
and needle dissection31 from samples of frozen-thawed
ovarian cortex obtained from a patient who was 29 at
the time of ovarian tissue cryopreservation; cryopreserva-
tion was performed by slow freezing for fertility preserva-
tion.32 Ovarian follicles were staged according to size and
morphology; samples were collected from the primordial,
early primary, and primary stage, and pooled between
25–40 follicles per sample. Denuded, mature metaphase
II (MII) oocytes were derived after 24 hr of in vitro matura-
tion of immature germinal vesicle (GV) or metaphase I
oocytes from patients undergoing infertility treatment
by intracytoplasmic sperm injection at the assisted
conception unit at Leeds General Infirmary. Additionally,
denuded, GV-staged secondary oocytes were harvested
from nonluteinized antral follicles of 5 mm diameter that
were aspirated from two patients during immature oocyte
recovery as previously described.28,29 All samples were ob-
tained after informed consent under ethically approved
protocols, which were licensed in the UK by the Human
Fertilisation and Embryology Authority. Day 6–7 human
blastocysts (total n ¼ 10) that were either considered
unsuitable for transfer and were donated for research or
that were surplus to the patients’ treatment requirements,
had been in cryostorage, and were donated for research; we
obtained the blastocysts with full patients’ consent from
the Assisted Conception Unit at Leeds General Infirmary
and Bourn Hall Clinic, Cambridge, UK, under ethically
approved protocols, which were licensed by the HFEA
as previously described.30 All samples were washed in
Ca2þ and Mg2þ-free phosphate buffered saline at 4C
(Invitrogen) before being snap frozen in 50 ml lysis buffer
(Dynal lysis buffer, Dynal, Merseyside, UK) supplemented
with 5 ml of RNA Later (Ambion, Austin, TX, USA) per
sample on ice, and mRNA was extracted using Oligo-dT
magnetic beads (Dynal, Oslo, Norway). cDNA was gener-
ated using SMART amplification (Clontech, Oxford, UK)
or a related cDNA amplification protocol33 with 1 mg
each of forward and reverse primers (details in Table S4).
In each case, reverse transcription was performed with
Superscript II RNaseH-Reverse Transcriptase (Invitrogen)
for 2 hr at 42C. The cDNA was amplified by PCR with
an additional 1 mg of each primer, 2 ml 503 Advantage 2
Polymerase (BD Clontech), in a thermal cycler for 32 cycles
of 95C for 45 s, 65C for 6 min 45 s. All cDNAs generated
were tested with the housekeeping gene (GAPDH).er 9, 2011
Figure 4. C6orf221 Expression in Human Ovarian Follicles,
Oocytes, Preimplantation Embryos
Expression of C6orf221 andGAPDHwas investigated by RT-PCR of
cDNA amplified from human ovarian follicles (including granu-
losa/pregranulosa cells), mature oocytes (granulosa/pregranulosa
cell free) and preimplantation embryos. DNA size standard:
lane1, primordial follicles (n ¼ 25–40); lane 2, early primary
follicles (n ¼ 25–40); lane 3, primary follicles (n ¼ 25–40); lane
4, GV oocyte pool (n ¼ 2); lane 5, MII oocyte pool (n ¼ 5); lane
6, Morula pool (n ¼ 5); lane 7, blastocyst pool 1 (n ¼ 5); lane 8,
blastocyst pool 2 (n ¼ 5); negative control (-ve). Diameters used
for follicle staging: primordial follicles 34–38 mm, early primary
follicles 34–53 mm, primary follicles 52–62 mm, secondary
follicles 62–86mm. The upper panel shows expression of expected
716 bp long C6orf221 mRNA; the lower panel shows expression
of the housekeeping gene GAPDH mRNA, used as a control.
Figure 5. Immunohistochemical Staining of Bovine Ovary for
C6orf221 Ortholog
The primary antibody was raised against the 15 N-terminal
amino acids (MASPKRFPTLVQLEQ) of predicted bovine protein
XP_002690064.1. (computationally predicted gene, C9H6orf221,
Bos taurus ES-cell-associated transcript). The following abbrevia-
tions are used: OSE, ovarian surface epithelium; Pr, primordial
(nongrowing) follicle; Tr, transitional follicle; 1, primary follicle;
2, secondary follicle; A, antral follicle; GC, granulosa cells; TC,
thecal cells. Protein is diffusely distributed throughout the cyto-
plasm of oocytes in the primary and secondary follicles. In the
antral follicles localization is again restricted to oocyte cytoplasm,
but the staining pattern now takes on a more punctate appear-
ance. There is no staining in surrounding granulosa or stromal
cells.Expression appeared to be maximal in germinal vesicle
oocytes (GV) and then to tail off through metaphase II
oocytes (MII) and to be undetectable following the
completion of the oocyte to embryo transition34 (Figure 4).
It may be noted that this temporal pattern of expression
of C6orf221 in oocytes is similar to that of NLRP7 re-
ported previously35 and is typical of the expression we
and others have previously reported for oocyte-specific
genes.29,36–38
In bovine ovary, an antibody to the N-terminal peptide
(MASPKRFPTLVQLEQC) of the apparent bovine ortholog
(NP_001017361.2) showed a pattern of staining restricted
to oocyte cytoplasm (Figure 5) in primary and secondary
follicles. In antral follicles the staining is again cytoplasmic
and takes on a punctate appearance.
C6orf221 is a member of a 100 kb cluster containing four
related genes, located at ~74 Mb on human chromosome
6.39 The other members of the family are KHDC1 (KH
domain containing 1 [MIM 611688]), DPPA5 (develop-
mental pluripotency associated 5 [MIM 611111]) and
OOEP (oocyte expressed protein [MIM 611689]). The
human gene order and orientation is (<KHDC1 < DPPA5
C6orf221 > < OOEP). Members of this gene family display
a mostly oocyte- or early embryo-specific expression
pattern.39 They are characterized structurally by an
N-terminal KH domain (K homology domain, some exam-
ples of which are known to be RNA binding).40 It should be
noted that there is some ambiguity regarding nomencla-
ture for members of this gene family in various mamma-
lian species. In the evolutionary analysis by Pierre
et al.,39 primate C6orf221 is referred to as ECAT1. In thisThe Americanstudy, Pierre et al. concluded that Ecat1 has been lost
from the rodent genome, coincident with a disruption
of synteny between the Dppa5/Ooep cluster (on Mmu9
at ~78.22 Mb) and Khdc1 (on Mmu1 21.35 Mb). However,
Ecat1 transcripts were actually originally identified in
mouse ES cells (Mm.157658, also known as Filia).41 In
the NCBI37/mm9 build, Mmu Ecat1/Filia can be found
on Mmu9 at 72.95 Mb, more than 5 Mb distant from
Dppa5/Ooep. This makes it somewhat uncertain whether
are not Ecat1/Filia and C6orf221 are true orthologs. In the
rabbit and cow genomes, the synteny and convergent tran-
scriptional orientation of ECAT1/C6orf221 and OOEP are
maintained, making orthology with the human genes
clearer. Sequence alignment of the human, bovine, rabbit,
and mouse genes (Figure S1) similarly leaves the orthology
ofMmu Ecat1with the other three genes uncertain because
although closely similar, it is the most divergent of the
four.
Regardless of precise cross-species orthology, theKHDC1/
DPPA5/C6orf221(ECAT1)/OOEP cluster appears to be
specific to eutherian mammals, in which these genes have
evolved rapidly.39 Interestingly, the same is also true for
the NLRP7/NLRP2 group of genes, within which cross-
species orthology is again difficult to establish.11,35,42
Indeed, these are evolutionary features characteristic of a
number of reproduction-related gene clusters.42 We alsoJournal of Human Genetics 89, 451–458, September 9, 2011 455
note, however, the existence of an additional, much
more highly conserved gene related to OOEP, C12orf66,
which unlike the members of the KHDC1/DPPA5/
C6orf221(ECAT1)/OOEP cluster, is present in nonmamma-
lian vertebrates.
The KH domain of the KHDC1/DPPA5/C6orf221
(ECAT1)/OOEP family is encoded by the first two of three
coding exons, followed by a variable C terminus. In the
ECAT1/C6orf221 genes, the C-terminal domain encoded
by exon 3 displays an interesting ~12 aa repeat motif,
with the size of different species’ proteins varying consid-
erably, due to variation in the number of repeats. In bovine
C6orf221, for example, there are 20 almost perfect tandem
repeats of the sequence EAATQRSPGAAR. In human
C6orf221, seven much less homogeneous TQRS-contain-
ing repeats are present, while the rabbit protein only
contains three. Murine Ecat1/Filia also has 18 12 aa repeats
of a slightly different sequence in this position.37 Closely
related repeat motifs could not be identified in any other
gene product, despite exhaustive search.
FBHM is currently the only known human maternal-
effect recessive disorder. Maternal-effect recessives have
been known since the 1980s in Drosophila, but only
much more recently in mammals. Interestingly, one of
the first maternal-effect genes identified in mice was
Mater/Nlrp543. Mater/Nlrp5 transcripts are expressed in the
growing oocyte, but the maternally-encoded protein
product is required early in embryogenesis. Mater/Nlrp5
protein associates specifically with Ecat1/Filia protein to
form a complex, which in the early embryo becomes pref-
erentially localized in those cells destined to form extraem-
bryonic structures.37 This subcortical maternal complex
(SCMC) also includes the product of another maternal-
effect gene related to Filia/Ecat1, namely Floped/Ooep.
There is evidence that the SCMC may be identical to the
oocyte ultrastructural organelles known as cytoplasmic
lattices (CPLs), since both the SCMC and CPLs are absent
from oocytes of Floped/Ooep null female mice.44
These observations, together with the fact that muta-
tions of C6orf221/ECAT1 and of NLRP7 have identical
phenotypes, make it likely that NLRP7 and C6orf221
participate in a similar complex during human oogenesis
and/or early embryogenesis. Because of the rapid evolution
of the members of both these gene families, precise infer-
ences based on presumed orthology should be made with
caution. Also, the substantial differences in female repro-
ductive physiology among mammalian groups must be
borne in mind. Although mutations of mouse Filia/Ecat1
and human C6orf221 both display maternal-effect reces-
sive inheritance, the phenotypes are not identical: Filia/
Ecat1 null female mice produce embryos with reduced
viability because of mitotic spindle dysfunction and chro-
mosomal aneuploidy.45 Although general inferences con-
cerning the biology of human NLRP7 and C6orf221 may
be drawn from the mouse studies, it is therefore likely
that a detailed picture will require the study of human
oocytes and embryos.456 The American Journal of Human Genetics 89, 451–458, SeptembSupplemental Data
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